Using a new technology for repairing disease genes—the much-talked-about CRISPR/Cas9 gene editing—University of Iowa researchers working together with Columbia University Medical Center ophthalmologists have corrected a blindness-causing gene mutation in stem cells derived from a patient. The result offers hope that eye diseases might one day be treated by personalized, precision medicine in which patients' own cells are used to grow replacement tissue.
↧